Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Appointment of Company Secretary and Compliance Officer

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), this is to inform you that the Board of Directors of the Company at its meeting held on March 31, 2022 have, inter-alia, considered the following: a) Noting of the resignation of Mr. Sumit Goel from the position of Company Secretary & Compliance Officer of the Company with effect from April 4, 2022 (close of business hours). b) Approved the appointment of Mr. Murlee Manohar Jain as Company Secretary & Compliance Officer of the Company with effect from April 5, 2022. Further, the detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/ CFD /CMD/4/2015 dated September 9, 2015 is enclosed as Annexure-A. This is for your information and record.
01-04-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), this is to inform you that the Board of Directors of the Company at its meeting held on March 31, 2022 have, inter-alia, considered the following: a) Noting of the resignation of Mr. Sumit Goel from the position of Company Secretary & Compliance Officer of the Company with effect from April 4, 2022 (close of business hours). b) Approved the appointment of Mr. Murlee Manohar Jain as Company Secretary & Compliance Officer of the Company with effect from April 5, 2022. Further, the detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/ CFD /CMD/4/2015 dated September 9, 2015 is enclosed as Annexure-A. This is for your information and record.
01-04-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Closure of Trading Window

 With reference to the provisions of Policy / Code of Conduct for Prevention of Insider Trading, the "Trading Window" for dealing in shares of the Company is closed from March 31, 2022 till 48 hours from declaration of financial results for the financial year ending on March 31, 2022. This is for your information and records please.
30-03-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Intimation Of Schedule Of Investors / Analysts' Meet Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 In compliance of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below schedule of upcoming Analyst / Institutional Investor Meeting with the Management of the Company. Date - March 16, 2022 Investors / Analysts / Events- Centrum Broking Limited - Hospital & Diagnostic Corporate Day Location- Virtual Conference No Unpublished Price Sensitive Information (UPSI) shall be shared / discussed at the investors / analysts' meet. This is for your kind information and records.
15-03-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Change In Name Of The Share Transfer Agent Of The Company From 'Kfin Technologies Private Limited' To 'Kfin Technologies Limited'

 We have been informed by the Share Transfer Agent of the Company that pursuant to conversion of its status from private limited company to public limited company, its name has been changed from 'KFin Technologies Private Limited' to 'KFin Technologies Limited'. The address and other contact details of Share Transfer Agent remain unchanged. For ready reference, contact details of KFin Technologies Limited is given below: KFIN Technologies Limited Selenium Building, Tower-B, Plot no.31 & 32, Financial District, Nanakramguda, Serlingampally, Hyderabad - 500 032, Telangana Phone: 040-67162222 Toll free: 18003094001 Email: einward.ris@kfintech.com Website: www.kfintech.com We request you to take note of the above and update in your records, the name of 'KFin Technologies Limited' as the Share Transfer Agent of the Company.
15-03-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

 In continuation to intimation made by the Company on March 7, 2022, this is to inform you that the Company has completed dispatch of postal ballot notice to its members on March 9, 2022 for seeking approval of the members by way of Special Resolution on the proposal detailed in Company's earlier intimation. Further, copies of newspaper advertisements published on March 10, 2022 in the columns of English daily 'Financial Express', all editions and Punjabi daily 'Rozana Spokesman', Mohali edition, inter-alia, intimating completion of the electronic transmission of Postal Ballot Notice along with the Postal Ballot Form to the Members, are enclosed for kind reference. This is for your kind information and records.
10-03-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 In compliance of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed schedule of upcoming Analyst / Institutional Investor Meetings with the Management of the Company. No Unpublished Price Sensitive Information (UPSI) shall be shared / discussed at the investors / analysts' meet. This is for your kind information and records.
08-03-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI LODR), this is to inform you that the Company is in process of issuing postal ballot notice to its members for seeking their approval by way of Special Resolution on the following proposal: a) Approval for amalgamation of Fortis Emergency Services Limited, Fortis Cancer Care Limited, Fortis Health Management (East) Limited and Birdie & Birdie Realtors Private Limited with Fortis Hospitals Limited (collectively wholly-owned subsidiaries). A copy of the postal ballot notice along with ballot form is enclosed for kind reference. Further, the said notice will be dispatched to the shareholders in this week. An intimation with respect to completion of dispatch and related compliance will be sent once the dispatch is complete. This is for your kind information and records.
07-03-2022

Fortis launches workplace mental health programme to deal with distress

 Initiative provides counselling, webinars to create a culture of openness and acceptance about mental health and real-time text chat support by a team of psychologists
04-03-2022
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Credit Rating

 In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please note that CRISIL Ratings Limited has upgraded Long Term Rating from 'CRISIL A+/ Watch Developing' to 'CRISIL AA-/ Watch Developing' for the Company. Further, the short-term rating has been upgraded from 'CRISIL A1/Watch Developing' to CRISIL A1+/Watch Developing for the Company. The detailed letter as issued by CRISIL Ratings Limited to the Company is attached for your reference and records.
25-02-2022
Next Page
Close

Let's Open Free Demat Account